The aminoglycoside streptomycin triggers ferroptosis in tumor initiating cells
Guillorit, H.; Relier, S.; Zagiel, B.; Di Giorgio, A.; Cazevieille, C.; Bansard, L.; Bouclier, C.; Mialhe, X.; Brisset, M.; Hideg, S.; Choquet, A.; Planque, C.; Bastide, A.; Pannequin, J.; Duca, M.; Macari, F.; David, A.
Show abstract
Compelling evidence suggests that tumor initiating cells (TIC) are the roots of current shortcomings in advanced and metastatic cancer treatment. TIC represents a minor subpopulation of tumor cells endowed with self-renewal and multi-lineage differentiation capacity, which can disseminate and seed metastasis in distant organ. Our work identified Streptomycin (SM), a potent bactericidal antibiotic, as a new molecule capable of targeting non-adherent TIC from colon and breast cancer cell lines by inducing mitochondrial-dependent ferroptosis. SM-induced ferroptosis associates with profound alterations in mitochondrial morphology, such as swelling and cristae enlargement, coupled with hyperpolarization of mitochondrial membrane potential and production of mitochondrial ROS. The peculiar SM structure, and more particularly its aldehyde group, is essential for this mechanism. As such, the mere reduction of SM into dihydrostreptomycin abolishes its effect on TIC. This study reveals a new mechanism of action of SM that could help comprehend the molecular basis of TIC adaptation to inhospitable environments and pave the way for new treatment of advanced cancers.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs 95%
- Amino acid restriction sensitizes lung cancer cells toferroptosis via GCN2-dependent activation of the integratedstress response 95%
- Unravelling the anti-cancer mechanisms elicited by non-covalent thioredoxin reductase inhibitors for triple negative breast cancer therapy. 95%
Similar papers in this journal
- Inhibition of mitochondrial dynamics preferentially targets pancreatic cancer cells with enhanced tumorigenic and invasive potential 94%
- Synthetic lethality screening identifies FDA-approved drugs that overcome ATP7B-mediated tolerance of tumor cells to cisplatin 94%
- Two antagonistic microtubule targeting drugs act synergistically to kill cancer cells 94%
Similar papers in this journal
- Quiescent OXPHOS-high triple-negative breast cancer cells that persist after chemotherapy depend on BCL-XL for survival 94%
- Boosting the biogenesis and secretion of mesenchymal stem cell-derived exosomes 92%
- Lactoferrin-Derived Peptide Chimera Induces Caspase-independent Cell Death in Multiple Myeloma 92%
Similar papers in this journal
- Identification of a cardiac glycoside exhibiting favorable brain bioavailability and potency for reducing levels of the cellular prion protein 94%
- A small molecule that promotes cellular senescence prevents fibrogenesis and tumorigenesis in vitro 92%
- Immune modulating drug MP1032 with SARS-CoV-2 antiviral activity in vitro: A potential multi-target approach for prevention and early intervention treatment of COVID-19 92%